Iron deficiency
Drug research and approvals for iron deficiency: what is recruiting, what Health Canada authorized, FDA orphan designations and EU medicines. See every condition.
As of Nov 16, 2026, 94 studies of iron deficiency are recruiting on ClinicalTrials.gov, Health Canada has authorized 5 drug trials for it since 2013, and the EU has 2 authorised medicines for it.
- Recruiting worldwide: 94
- Trials authorized in Canada: 5
- FDA orphan approvals: 0
- EU medicines: 2
Recruiting Now
Newest start dates first, of 94 recruiting on ClinicalTrials.gov ↗- Iron Absorption From a Nutritional Iron SupplementNCT07921433 · Not applicable · ETH Zurich · starts Nov 1, 2026
- A Phase 3 Evaluation of Sutacimig in Glanzmann ThrombastheniaNCT07935356 · Phase 3 · Hemab ApS · starts Oct 27, 2026
- Tranexamic Acid for Anaemia TrialNCT06519422 · Phase 3 · London School of Hygiene and Tropical Medicine · starts Aug 10, 2026
- Iron Status Assessment in Geriatric ElderlyNCT07739524 · Not reported · Centre Hospitalier Régional d'Orléans · starts Aug 4, 2026
- Iron Deficiency at ICU DischargeNCT07781540 · Not reported · Università degli Studi di Ferrara · starts Jul 29, 2026
- A Study of Ferric Derisomaltose Injection in Chinese Participants With Iron Deficiency Anemia Under Fasting ConditionsNCT07790562 · Phase 1 · Sichuan Huiyu Pharmaceutical Co., Ltd · starts Jul 23, 2026
- Preconception vs First-Trimester Screening and Treatment for Iron Deficiency AnemiaNCT07811765 · Not applicable · Xinhua Hospital, Shanghai Jiao Tong University School of Medicine · starts Jul 10, 2026
- Impact of Two Iron Formulations on Iron Biomarkers and Quality of LifeNCT07156526 · Not applicable · Qualia Life Sciences · starts Jun 18, 2026
- A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of CTX001 in Healthy Adults.NCT07577817 · Early Phase 1 · Cajal Therapeutics Inc. · starts Jun 1, 2026
- FACE-APPS-Based Approach for Improving Iron Deficiency Anaemia Indicators Among Female Adolescents at Marginalized…NCT07633262 · Not applicable · Cairo University · starts May 24, 2026
Trials Authorized in Canada
Newest first; search them all in Canada trials| Feb 12, 2025 | A phase III, randomised, open-label, blinded endpoint, comparative trial of ferric derisomaltose versus no intravenous iron in iron-deficient subjects with…FERRIC DERISOMALTOSE | Pharmacosmos | Ongoing |
| Nov 24, 2022 | Post-operative intravenous iron to treat iron-deficiency anemia in patients undergoing cardiac surgery: a pilot, multicentre, placebo-controlled randomized…FERRIC DERISOMALTOSE | UNIVERSITY HEALTH NETWORK | Ongoing |
| Jun 1, 2022 | Feasibility and efficacy of intravenous ferric derisomaltose to correct pre-operative iron-deficiency anemia in patients undergoing gynecologic oncology…FERRIC DERISOMALTOSE | ALBERTA HEALTH SERVICES | Ongoing |
| Feb 15, 2022 | Intravenous iron isomaltoside versus iron sucrose for treatment of iron deficiency in pregnancy: randomized, comparative trialFERRIC DERISOMALTOSE / IRON SUCROSE | SASKATCHEWAN HEALTH AUTHORITY Âż REGINA AREA | Ongoing |
| Jul 17, 2017 | Protocol title: a randomized, double-blind, placebo-controlled study to investigate the efficacy and safety of ferric carboxymaltose (us trade name:…FERRIC CARBOXYMALTOSE | Daiichi Sankyo | Ongoing |
Medicines Authorised in the EU
Newest first| Jun 11, 2025 | Xoanacylferric citrate coordination complex | Averoa | EMA ↗ |
| Feb 18, 2016 | Feraccruferric maltol | Norgine B.V. | EMA ↗ |
Condition names come from Health Canada's trial database. Orphan designations and EU medicines are matched when their indication names the condition as whole words, so a broader or differently worded indication can be missed. Recruiting counts are live from ClinicalTrials.gov's own condition search, refreshed daily. ClinicalTrials.gov, Health Canada Clinical Trials Database, FDA orphan designations, EMA